AF Summit: The Current Status and Future of AF Therapeutic Technology

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon
This all-day program provides a comprehensive and state-of-the art review of the field of atrial fibrillation (AF) ablation. Particular emphasis is placed on the role of technology in the field of AF ablation. The AF Summit will also showcase the recipient of the Founders’ Lectureship Award.

The Basic Science of AF Ablation
8:00 – 9:45 a.m.
Session Description: This session provides a state-of-the-art review of the science that underlies AF ablation as a therapeutic modality.
Chairs:
  • Shih-Ann Chen, MD, Taipei Veterans General Hospital, Taipei, Taiwan
  • Albert L. Waldo, MD, Case Western Reserve University/University Hospital, Cleveland

Summit Introductions and Overview
Hugh Calkins, MD, Johns Hopkins Hospital, Baltimore

Experimental Insights into AF Ablation Mechanisms
Stanley Nattel, MD, Montreal Heart Institute, Montreal

Atrial Electrograms to Guide AF Ablation: Where Is the Science?
Jose Jalife, MD, University of Michigan, Ann Arbor, Mich.

Autonomic Innervation of the PVs and Atrium: Is This the Missing Link?
Warren M. Jackman, MD, University of Oklahoma Health Sciences Center, Oklahoma City, Okla.

Heart Rhythm Society's Founders' Lecture Award — Atrial Remodeling: Does this Explain the Poor Outcomes of Ablation of Longstanding AF?
Maurits Allessie, MD, PhD, Maastricht University, Maastricht, The Netherlands

Panelist:
  • Shih-Ann Chen, MD, Taipei Veterans General Hospital, Taipei, Taiwan
  • Albert L. Waldo, MD, Case Western Reserve University Cleveland
  • Stanley Nattel, MD, Montreal Heart Institute, Montreal
  • Jose Jalife, MD, FHRS. University of Michigan, Ann Arbor, Mich.
  • Warren M. Jackman, MD, FHRS. Univ of Oklahoma Health Sciences Center, Oklahoma City
  • Maurits Allessie, MD, Ph.D. Maastricht University, Maastricht, Netherlands

Break: 9:45 – 10:15 a.m.

Technology in AF Ablation: Now and in the Future
10:15 a.m. – 12:00 p.m.
Session Description: A state-of-the-art review of the current and emerging technologies that are used during AF ablation procedures.

Chairs:
  • Shih-Ann Chen, MD. Taipei Veterans General Hospital, Taipei, Taiwan
  • D. Wyn Davies, MD. St. Mary's Hospital, London, United Kingdom

Current Approach and Outcomes of AF Ablation
Hugh Calkins, MD, FHRS, CCDS. Johns Hopkins Hospital, Baltimore, Md.

Balloon, Contact Monitoring and Other New Ablation Tools
Karl-Heinz Kuck, MD. Asklepios Klinik St. Georg, Hamburg, Germany

Linear Lesions and Ablation of Complex Fractionated Atrial Electrograms: What Do They Add?
Prashanthan Sanders, PhD, University of Adelaide, Adelaide, Australia

MRI: Is there a Role in 2011?
Nassir F. Marrouche, MD. University of Utah, Salt Lake City

Image Based Navigation Technologies: Integrating Robotics and Ablation in 2011
Douglas Packer, MD. Mayo Clinic - St. Mary's Hospital, Rochester, Minn.

Panelist:
  • John M. Miller, MD. Indiana University School of Medicine, Indianapolis
  • Bruce D. Lindsay, MD, FHRS, CCDS. Cleveland Clinic Foundation, Cleveland
  • Hans Kottkamp, MD. Clinic Hirslanden – Heart Center, Zurich, Switzerland
  • Gregory K. Feld, MD, FHRS, CCDS. University of California-San Diego, San Diego, Calif.

Lunch: noon – 12:30 p.m. (Lunch provided to Summit attendees)

AF Ablation in 2011 and Beyond
12:30–2:00 p.m.
Session Description: An up-to-date review of the outcomes and AF ablation in less studied populations of patients, including those with long standing persistent AF, the elderly, and those with heart failure.

Chairs:
  • Sabine Ernst, MD, PhD, Royal Brompton Hospital, London
  • John D. Day, MD,  Intermountain Medical Center, Salt Lake City

AF Ablation in Very Long Standing Persistent AF: Current Results and Future Possibilities
Pierre Jais, MD. Hopital Du Haut-Leveque, Bordeaux, France

AF Ablation in Heart Failure
David J. Wilber, MD, Loyola University Medical Center, Maywood, Ill.

AF Ablation in the Elderly
David J. Callans, MD, University of Pennsylvania, Philadelphia

Panelist:
  • Francis E. Marchlinski, MD, University of Pennsylvania Health System, Philadelphia
  • Walid I. Saliba, MD, Cleveland Clinic Foundation, Cleveland
  • Chang Sheng Ma, MD, Beijing Anzhen Hospital, Dept of Cardiology, Beijing, China
  • Shih-Ann Chen, MD, Taipei Veterans General Hospital, Taipei, Taiwan
  • David J. Wilber, MD, FHRS, Loyola University Medical Center, Maywood, Ill.

Break: 2:00 – 2:15 p.m.

Current, Evolving and Futuristic Therapies for AF
2:15 – 3:45 p.m.
Session Description: Astate-of-the-art review of the current, evolving, and futuristic therapies for AF ablation and management.
Chairs:
  • Eric N. Prystowsky, MD, FHRS. The Care Group, LLC, Indianapolis, IN
  • Riccardo Cappato, MD, FHRS. IRCCS Policlinico San Donato, San Donato Milanese, Italy

This Is How I Ablate AF
Andrea Natale, MD, FHRS. Texas Cardiac Arryhthmia Institute, Austin, Texas
Moussa Mansour, MD. Massachusetts General Hospital, Boston
Dipen C. Shah, MD. Hopital Cantonal De Geneve, division of cardiology, Geneva, Switzerland
Carlo Pappone, MD, Ph.D. Hospital San Raffaele, Milano, Italy

AF Ablation in the Bigger Picture: Views from the Latest Guidelines
Anne M. Gillis, MD, FHRS. University of Calgary/Calgary Health Region, Calgary, Alberta

Micro RNAs as Therapeutic Targets
Stanley Nattel, MD, FHRS. Montreal Heart Institute, Montreal

New Anticoagulants and LA Appendage Occlusion Devices for Stroke Prevention
A. John Camm, MD, FHRS. St. George's Hospital Medical School, London

Closing Remarks
David J. Callans, MD, University of Pennsylvania, Philadelphia

Note: The Current Status and Future of AF Therapeutic Technology video and audio presentations will be streamed to a virtual "conference room" — if you can't attend in person, register for the Virtual AF Summit to participate interactively live or to access presentations on-demand.